Thane Wettig Fibrogen Inc (FGEN) insider trading activity

Thane Wettig is CEO of FIBROGEN INC. Currently has a direct ownership of 24,680 shares of FGEN, which is worth approximately $214,469. The most recent transaction as insider was on Aug 07, 2023, when has been sold 200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.7K

16.2% 3M change

94.12% 12M change

Total Value Held $214,469

Thane Wettig Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 07 2023	BUY Grant, award, or other acquisition	-	200,000 Added 39.35%	308,261 Common Stock
Jun 23 2023	SELL Open market or private sale	$13,075 $16.53 p/Share	791 Reduced 0.73%	108,261 Common Stock
Jun 07 2023	SELL Open market or private sale	$29,956 $17.04 p/Share	1,758 Reduced 1.55%	111,395 Common Stock
Mar 23 2023	SELL Open market or private sale	$16,932 $18.71 p/Share	905 Reduced 0.81%	110,653 Common Stock
Mar 20 2023	SELL Bona fide gift	-	2,343 Reduced 2.12%	108,310 Common Stock
Mar 10 2023	SELL Open market or private sale	$154,913 $20.2 p/Share	7,669 Reduced 6.43%	111,558 Common Stock
Mar 08 2023	SELL Open market or private sale	$132,567 $21.16 p/Share	6,265 Reduced 5.68%	104,090 Common Stock

Mar 08 2023	BUY Grant, award, or other acquisition	-	15,137 Added 11.27%	119,227 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	25,000 Added 18.47%	110,355 Common Stock
Dec 23 2022	SELL Open market or private sale	$11,597 $15.8 p/Share	734 Reduced 0.82%	89,163 Common Stock
Dec 08 2022	SELL Open market or private sale	$6,031 $15.79 p/Share	382 Reduced 0.42%	89,897 Common Stock
Sep 22 2022	SELL Payment of exercise price or tax liability	$8,030 $12.26 p/Share	655 Reduced 0.72%	90,279 Common Stock
Sep 06 2022	SELL Payment of exercise price or tax liability	$4,414 $12.26 p/Share	360 Reduced 0.39%	90,934 Common Stock
Jun 22 2022	SELL Payment of exercise price or tax liability	$7,480 $11.42 p/Share	655 Reduced 0.71%	91,294 Common Stock
Jun 06 2022	SELL Payment of exercise price or tax liability	$3,420 $9.5 p/Share	360 Reduced 0.4%	89,961 Common Stock
Mar 22 2022	SELL Payment of exercise price or tax liability	$8,718 $13.31 p/Share	655 Reduced 0.72%	90,321 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$21,649 $12.69 p/Share	1,706 Reduced 1.84%	90,976 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	45,000 Added 32.68%	92,682 Common Stock
Dec 22 2021	SELL Payment of exercise price or tax liability	$7,739 $14.97 p/Share	517 Reduced 1.07%	47,682 Common Stock
Sep 22 2021	SELL Payment of exercise price or tax liability	$6,312 $10.18 p/Share	620 Reduced 1.27%	48,196 Common Stock
Aug 26 2021	BUY Open market or private purchase	$35,743 $11.53 p/Share	3,100 Added 5.97%	48,816 Common Stock
Jun 22 2021	SELL Payment of exercise price or tax liability	$71,696 $27.65 p/Share	2,593 Reduced 5.37%	45,716 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	16,500 Added 25.92%	47,150 Common Stock

Thane Wettig

CEO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Fibrogen Inc insider buys or sells FGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to FIBROGEN INC

Track Activities on FGEN

Account